• IPO proceeds utilization: Out of the ₹8,000 crore fresh issue, ₹6,000–₹6,500 crore will be used to clear NCDs, interest, and remaining obligations from the Sahyadri acquisition, while ₹1,500 crore will go toward general corporate purposes.
• Net debt elimination: The company holds ₹10,000 crore in gross debt and ₹2,500 crore in cash, making it practically net debt-zero on day zero upon receiving the ₹8,000 crore primary equity infusion.
• Cash reserves strategy: Post-IPO cash balances will rise to ₹4,000 crore, providing liquidity to strategically repay lower-cost term loans or fund expansion initiatives.
• Network capacity expansion: The company plans to add approximately 3,000 greenfield and brownfield hospital beds over the next three years at a total estimated investment of ₹4,000 crore.